According to STAAR Surgical's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 6.49463. At the end of 2023 the company had a P/S ratio of 4.73.
Year | P/S ratio | Change |
---|---|---|
2023 | 4.73 | -42.57% |
2022 | 8.23 | -56.37% |
2021 | 18.9 | -15.62% |
2020 | 22.3 | 113.92% |
2019 | 10.4 | -8.18% |
2018 | 11.4 | 60.72% |
2017 | 7.08 | 32.04% |
2016 | 5.36 | 45.18% |
2015 | 3.69 | -21.36% |
2014 | 4.70 | -43.84% |
2013 | 8.36 | 140.05% |
2012 | 3.48 | -42.17% |
2011 | 6.02 | 54.69% |
2010 | 3.89 | 108.35% |
2009 | 1.87 | 99.4% |
2008 | 0.9373 | -28.52% |
2007 | 1.31 | -58.54% |
2006 | 3.16 | -17.57% |
2005 | 3.84 | 53.08% |
2004 | 2.51 | -39.02% |
2003 | 4.11 | 211.74% |
2002 | 1.32 | -1.01% |
2001 | 1.33 |
Company | P/S ratio | P/S ratio differencediff. | Country |
---|---|---|---|
Novartis NVS | 4.20 | -35.38% | ๐จ๐ญ Switzerland |
Abbott Laboratories ABT | 4.55 | -29.97% | ๐บ๐ธ USA |
Cooper Companies COO | 5.31 | -18.28% | ๐บ๐ธ USA |
Atrion ATRI | 4.74 | -27.05% | ๐บ๐ธ USA |
SurgePays SURG | 0.5709 | -91.21% | ๐บ๐ธ USA |